Skip to main content

Closed

BDTX: Black Diamond Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-43.6%

Financially safe

Stretched

Debt / equity0.17×

Interest coverage0.0×

Current ratio8.46×

Black Diamond Therapeutics, Inc.

BDTXNASDAQ Global Select·USD·Closed

Black Diamond Therapeutics, Inc.

BDTXNASDAQ·USD·Closed

$1.69

−1.46%

$1.69

−$0.03 (1.46%)

52W Range

3thpctl

Volume

0.36×avg

Mkt Cap

96.84MUSD

P/E

-2.3TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.36×avg

Market Cap

96.84MUSD

P/E Ratio

-2.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings